DRTS

Alpha Tau Medical Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 2/10
  • Momentum↑ 9/10
Alpha Tau Medical sales and earnings growth
DRTS Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -20.00%
  • FCF Y/Y↓ -0.59%
Alpha Tau Medical gross and profit margin trends
DRTS Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -37.50%
Alpha Tau Medical net debt vs free cash flow
DRTS Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.1
  • Interest coverage↓ -15.2

Alpha Tau Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗